Abstract
IntroductionChinese Materia Medica (CMM) provides medical treatment and healthcare worldwide. However, precision quality control of CMM is considered a bottleneck in Chinese herbal modernization. Considering the multi-efficacy of the clinical applications of CMM, we adopted a novel strategy based on the efficacy network target to screen for efficacy-related constituents and efficacy markers. MethodsNetwork pharmacology and high-throughput molecular docking were integrated to construct efficacy network targets for activating blood (AB), cooling blood (CB), and easing mind (EM) in Danshen (Salvia miltiorrhiza Bge.). Cytoscape with plugins was used to analyze the structure and function of the networks. The efficacy scores of the components were calculated and ranked to identify efficacy markers, which were further verified using the PubChem database. ResultsFollowing 9164 ligand-receptor molecular docking, 328 AB efficacy targets, 88 CB efficacy targets, and 52 EM efficacy targets were validated in silico. Three efficacy network targets were then constructed, and topological and functional analyses showed that the networks were consistent with the corresponding efficacy. Six AB, three CB, and five EM efficacy markers were screened using comprehensive analysis. Most of the indices (13/14) were confirmed to be associated with matching efficacy. ConclusionThe indices selected based on efficacy level could satisfy the clinical requirements of traditional Chinese medicine (TCM). Therefore, the strategy would be conducive to providing a new approach for natural product-based drug discovery and achieving accurate quality control for Danshen following multi-efficacy application.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.